Partex NV is ​the first digital ​pharma platform that is set to be the largest AI-powered Drug Assets Manager. 

With the power of AI at its core, we at Partex NV Group deliver faster, lower-cost healthcare innovations, validated by wet-lab and real-world evidence. Our pioneering digital platform enables smarter decision-making throughout the entire value chain.

What sets us ​apart:
​- Within the Partex ​ecosystem, patients ​​keep ownership of ​their data and they are rewarded for ​participating in research projects
- ​Our ​AI/ML algorithms enable key ​industry players to develop life-saving drugs while also developing our own drug assets
- A ​strong history of success and ​performance: from humble software beginnings to a ​fully-fledged platform with over ​250 employees in 3 continents

Our vision is to transform the ​Life science Industry​ by curing incurable diseases and increasing humanity's longevity. We dare to care!

​We have a global presence that extends from ​APAC to ​the Americas, with offices currently in India, Germany, Switzerland and ​USA.

CEO & Co-Founder: Dr. Gunjan Bhardwaj
Chairman & Co-Founder: Francisco Fernandez

Companies belonging to Partex group: 
www.innoplexus.com
www.cureteq.com
www.perpetualblock.io
www.amrit.ai
www.assay.works

Health Data

Pharmaceutical

AI/ML

Life Sciences

Partex

Partex's headquarters in Eschborn, Germany

Gunjan Bhardwaj

Karen P. Zimmer

Dr. Michael Schulz

Bhupesh Khimani

Tamara K.

Sanjee Tawde

Sven Krause

Volker Menschik

Description

People (4)

Gunjan Bhardwaj

Nidhi Duhan

Sakina Ghadiali

Klaus Ferber